Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers (Q24545856)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers	scientific article

Statements

scholarly article

0 references

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers (English)

0 references

Escherichia coli

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Anna Rudin

3

author given names

Anna

author last names

Rudin

1 reference

24 October 2023

10

object named as

Jan Holmgren

author given names

Jan

author last names

Holmgren

1 reference

24 October 2023

Kingston H Mills

1 reference

ORCID Public Data File 2021

5

author given names

Audino

author last names

Podda

object named as

Audino Podda

1 reference

24 October 2023

author name string

Iain Stephenson

1

author given names

Iain

author last names

Stephenson

1 reference

24 October 2023

Maria C Zambon

2

author given names

Maria C

author last names

Zambon

1 reference

24 October 2023

Anthony Colegate

4

author given names

Anthony

author last names

Colegate

1 reference

24 October 2023

Roberto Bugarini

6

author given names

Roberto

author last names

Bugarini

1 reference

24 October 2023

Giusseppe Del Giudice

7

author given names

Giusseppe

author last names

Del Giudice

1 reference

24 October 2023

Ada Minutello

8

author given names

Ada

author last names

Minutello

1 reference

24 October 2023

Susan Bonnington

9

author given names

Susan

author last names

Bonnington

1 reference

24 October 2023

Kingston H G Mills

11

0 references

Karl G Nicholson

12

author given names

Karl G

author last names

Nicholson

1 reference

24 October 2023

language of work or name

0 references

publication date

May 2006

0 references

Journal of Virology

0 references

80

0 references

4962-70

0 references

10

0 references

Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

24 March 2017

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Healthcare workers and their attitudes to influenza vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Is there a role for a mucosal influenza vaccine in the elderly?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Mucosal immune responses to pneumococcal polysaccharides: implications for vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Determinants of immunity to influenza infection in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

27 September 2017

Reduced Infectivity of Cold-Adapted Influenza A H1N1 Viruses in the Elderly: Correlation with Serum and Local Antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

30 May 2018

Distribution and removal of human serum albumin-technetium 99m instilled intranasally

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

30 May 2018

Mucosal antibody response induced with a nasal virosome-based influenza vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

28 November 2018

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

28 November 2018

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

28 November 2018

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

28 November 2018

Molecular analysis of an outbreak of influenza in the United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

28 November 2018

Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472052

28 November 2018

Intranasal drug delivery by spray and drops

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza vaccines: present and future

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal immunity to influenza without IgA: an IgA knockout mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/16641287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JVI.80.10.4962-4970.2006

0 references

release_gzfjtaglgbh25onqlryyvtnwzq

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24545856&oldid=2042150419"